Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Limited has filed a compliance statement confirming no deviation or variation in the use of proceeds from its Rights Issue. The company raised Rs. 4,845.05 lakhs through a rights issue with allotment on 21st February 2024. The funds were deployed across five stated objects: acquiring equity shares of Derren Healthcare Private Limited (Rs. 1,443.58 lakhs), repaying borrowings (Rs. 289 lakhs utilized out of Rs. 588 lakhs allocated), working capital financing (Rs. 1,650 lakhs), general corporate purposes (Rs. 1,138.47 lakhs), and issue expenses (Rs. 25 lakhs). The Audit Committee reviewed the utilization statement and had no comments.
This is a routine regulatory filing showing the company is using rights issue proceeds as originally intended. For shareholders, this confirms proper deployment of funds without any deviation, which is a positive compliance indicator.